• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Comparison of the effects of calcipotriol, prednicarbate and clobetasol 17-propionate on normal skin assessed by ultrasound measurement of skin thickness.

作者信息

Lévy J, Gassmüller J, Schröder G, Audring H, Sönnichsen N

机构信息

Schering AG, Berlin, FRG.

出版信息

Skin Pharmacol. 1994;7(4):231-6. doi: 10.1159/000211299.

DOI:10.1159/000211299
PMID:8024805
Abstract

In this study, we investigated the effect of calcipotriol, prednicarbate and clobetasol 17-propionate on skin thickness over a treatment period of 6 weeks. The study was conducted as a controlled, randomized, double-blind comparison. The influence of these drugs on normal skin under occlusive conditions was assessed visually and by measuring skin thickness using 20 MHz B mode ultrasound. Both topically applied glucocorticosteroids lead to a significant decrease in skin thickness. In contrast to the glucocorticosteroid-induced atrophy, calcipotriol application on normal skin leads to an increase in skin thickness in all volunteers. The effect remains constant for the duration of treatment. The cause of this increase seems to be an irritative reaction of the skin which was histologically investigated in one volunteer. The histological features of this reaction are characteristic for a subacute dermatitis. The implications of these findings for the therapeutic mechanism of calcipotriol are discussed.

摘要

相似文献

1
Comparison of the effects of calcipotriol, prednicarbate and clobetasol 17-propionate on normal skin assessed by ultrasound measurement of skin thickness.
Skin Pharmacol. 1994;7(4):231-6. doi: 10.1159/000211299.
2
0.25% prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream.0.25%的丙缩羟强的松龙乳膏及其相应的赋形剂比0.1%的倍他米松-17-戊酸酯乳膏和0.05%的丙酸氯倍他索乳膏引起的皮肤萎缩更少。
Eur J Clin Pharmacol. 1992;42(2):159-61. doi: 10.1007/BF00278477.
3
Effects of calcipotriol and clobetasol-17-propionate on UVB-irradiated human skin: an immunohistochemical study.卡泊三醇和丙酸氯倍他索对紫外线B照射的人体皮肤的影响:一项免疫组织化学研究。
Skin Pharmacol. 1996;9(6):355-65. doi: 10.1159/000211446.
4
Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.丙酸氯倍他索序贯卡泊三醇在银屑病局部治疗中优于单用卡泊三醇。
J Eur Acad Dermatol Venereol. 1998 Jul;11(1):19-24.
5
Nail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream.甲银屑病:使用卡泊三醇乳膏和丙酸氯倍他索乳膏的联合治疗
Acta Derm Venereol. 2002;82(2):140. doi: 10.1080/00015550252948220.
6
Local tolerability of topically applied methylprednisolone aceponate.局部应用丙酸倍氯米松的局部耐受性。
J Am Acad Dermatol. 1993 May;28(5 Pt 1):786-8. doi: 10.1016/s0190-9622(09)80275-2.
7
Different skin thinning potential of equipotent medium-strength glucocorticoids.等效中效糖皮质激素不同的皮肤变薄潜力。
Skin Pharmacol Appl Skin Physiol. 2002 Mar-Apr;15(2):85-91. doi: 10.1159/000049394.
8
Topical hydrocortisone, clobetasol propionate, and calcipotriol do not increase photocarcinogenesis induced by simulated solar irradiation in hairless mice.外用氢化可的松、丙酸氯倍他索和卡泊三醇不会增加无毛小鼠模拟太阳辐射诱导的光致癌作用。
Exp Dermatol. 2010 Nov;19(11):973-9. doi: 10.1111/j.1600-0625.2009.01034.x.
9
Topical glucocorticoids of the non-fluorinated double-ester type. Lack of atrophogenicity in normal skin as assessed by high-frequency ultrasound.非氟化双酯型局部用糖皮质激素。通过高频超声评估,其在正常皮肤中无萎缩性。
Acta Derm Venereol. 1992;72(3):214-6.
10
0.05% clobetasol 17-propionate cream and ointment but not the corresponding 0.1% triamcinolone acetonide preparations increase skin surface roughness: a possible dissociation of unwanted epidermal and dermal effects.0.05%丙酸氯倍他索乳膏和软膏,但相应的0.1%曲安奈德制剂不会增加皮肤表面粗糙度:不良表皮和真皮效应可能存在分离。
Skin Pharmacol. 1996;9(2):120-3. doi: 10.1159/000211407.

引用本文的文献

1
Psoriasis and Treatment: Past, Present and Future Aspects.银屑病及其治疗:过去、现在和未来的各个方面。
Acta Derm Venereol. 2020 Jan 30;100(3):adv00032. doi: 10.2340/00015555-3386.
2
Differential activity of 2-methylene-19-nor vitamin D analogs on growth factor gene expression in rhino mouse skin and comparison to all-trans retinoic acid.2-亚甲基-19-去甲维生素D类似物对犀牛小鼠皮肤生长因子基因表达的差异活性及与全反式维甲酸的比较。
PLoS One. 2017 Nov 28;12(11):e0188887. doi: 10.1371/journal.pone.0188887. eCollection 2017.
3
TNF-α increases the expression and activity of vitamin D receptor in keratinocytes: role of c-Jun N-terminal kinase.
肿瘤坏死因子-α增加角质形成细胞中维生素D受体的表达和活性:c-Jun氨基末端激酶的作用
Dermatoendocrinol. 2016 Jan 8;8(1):e1137399. doi: 10.1080/19381980.2015.1137399. eCollection 2016 Jan-Dec.
4
Topical corticosteroid-induced skin atrophy: a comprehensive review.外用糖皮质激素引起的皮肤萎缩:综述
Drug Saf. 2015 May;38(5):493-509. doi: 10.1007/s40264-015-0287-7.
5
Fluorescence spectroscopy as a tool to detect and evaluate glucocorticoid-induced skin atrophy.荧光光谱法作为一种检测和评估糖皮质激素诱导皮肤萎缩的工具。
Lasers Med Sci. 2012 Sep;27(5):1059-65. doi: 10.1007/s10103-011-1045-4. Epub 2012 Jan 17.
6
Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin.外用糖皮质激素在重构表皮和人离体皮肤中的透皮吸收及代谢
Pharm Res. 1999 Sep;16(9):1386-91. doi: 10.1023/a:1018946924585.
7
Topical glucocorticoids with improved risk-benefit ratio. Rationale of a new concept.具有改善风险效益比的外用糖皮质激素。一个新概念的基本原理。
Drug Saf. 1996 Jun;14(6):375-85. doi: 10.2165/00002018-199614060-00003.